WOWONCOLOGY
Scientific Committee
About Prof. Ozden Altundag, MD, FICS
Prof. Ozden Altundag graduated from Ankara University Faculty of Medicine in 1993. Between 1993-2001, she studied Internal Medicine and Medical Oncology at Hacettepe University Faculty of Medicine, Ankara Turkiye. Between 2004-2006, she worked as a clinical postdoctoral research fellow in the Department of Thoracic & Head and Neck Cancer Medicine at the MD Anderson Cancer Center in Houston, TX, USA. She has been working as a faculty member at Baskent University Ankara Hospital since 2007. She is particularly interested in lung cancer, gynecological cancers, immunotherapy and ctDNAs.
She is a member of ASCO, ESMO, IASLC, MEMAGO, Turkish Gynecological-Oncology Society and Turkish Lung Cancer Society. She made presentations on gynecological and lung cancers in many international and national meetings. She has been involved more than 30 international lung and gynecological cancer clinical trials, published more than 150 peer viewed articles and the number of citations are more than 10000.
She has been selected in to IASLC Committee Member for the Global Multidisciplinary Practice Standards for the 2023-2025 term and extended to 2025-2027 also She is the Co-Chair of Special Populations subgroup of GMPSC. In August 5, 2025 She has been elected into the Fellow of the International Collage of Surgeon ((FICS) in Oncology (Turkey Section).
About Prof. Fadila Kouhen, MD, PhD
Prof. Fadila Kouhen, MD, PhD, is Full Professor of Radiation Oncology at Mohammed VI University of Health Sciences (UM6SS), Morocco. A dedicated clinician, researcher, and educator, she is committed to advancing cancer care through innovation, multidisciplinary collaboration, and evidence-based practice.
Her clinical expertise spans breast, gynecological, thoracic, genitourinary, and central nervous system malignancies, with special interest in stereotactic body radiotherapy (SBRT), adaptive radiotherapy, image-guided radiotherapy, and precision oncology.
She leads national and international research in advanced radiotherapy, artificial intelligence, radiomics, and personalized treatment, while championing prevention, women’s health, and equitable access to high-quality care, particularly in low- and middle-income settings.
Prof. Dr. Mohanad Al Ansari
Scientific Committee Member
Board Certified Surgeon – Robotic Surgical
Oncology
Minimal Invasive GI
Canadian Specialist Hospital Dubai
CEO – Metaverse Surgical Hospital USA